A new study identifies 44 genetic variants associated with depression among which 30 are newly discovered. The findings of the study are published in Nature Genetics. The study, by the Psychiatric Genomics Consortium and co-led in the UK by King's College London, is the largest study to-date of genetic risk factors for major depression.
‘Depression is a common disorder that affects nearly 14% of the global population. A new study identifies 44 genetic variants linked to an increased risk of depression and psychiatric disorders such as schizophrenia.’The study finds that the genetic basis for major depression is shared with other psychiatric disorders such as schizophrenia and that all humans carry at least some of the 44 genetic risk factors identified in the study.
Tweet it Now
A significant number of the genetic variants identified in the study are directly linked to the targets of current antidepressant medications. Analysis of the data also suggests that having higher BMI is linked to an increased risk of major depression.
Previous studies have struggled to identify more than a handful of genetic variants associated with depression. By combining seven separate datasets, the research team included data on more than 135,000 people with major depression and more than 344,000 controls.
The study was an unprecedented global effort by over 200 scientists who work with the Psychiatric Genomics Consortium and was led by the University of North Carolina School of Medicine and the University of Queensland in Australia. Professor Cathryn Lewis and Dr. Gerome Breen of King's College London led the UK contribution, along with scientists and psychiatrists from the Universities of Edinburgh, Cardiff, and UCL.
'With this study, depression genetics has advanced to the forefront of genetic discovery,' says Dr. Breen from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London. 'The new genetic variants discovered have the potential to revitalize depression treatment by opening up avenues for the discovery of new and improved therapies."
'Depression is an incredibly common disorder that affects millions of people in the UK,' says Professor Lewis of the IoPPN, who is leading efforts to conduct even larger international studies.
In the UK, the work was partly-funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, and the Medical Research Council.